and Vendor Assessment and Analysis, Cell and Gene Therapy, competitive analysis, data aggregation, Expanded Access Programs, Fair Market Value assessment, financial modeling, HUBs, Managed Access Programs, Market Access, Market Intelligence, Named Patient Programs, Operational Optimization, Pharmaceutical Channel Partner Selection, Pharmaceutical Distribution Strategies, Pharmaceutical Launch Strategies, Pharmaceutical Patient Support Programs, Pharmaceutical Technology, Project Management, qualitative market research, Quality Management, real-world benchmarking, RFP support, specialty pharmacy